Literature DB >> 8763815

Autoimmune T cells in myasthenia gravis: heterogeneity and potential for specific immunotargeting.

S Hawke1, H Matsuo, M Nicolle, G Malcherek, A Melms, N Willcox.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8763815     DOI: 10.1016/0167-5699(96)10022-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  5 in total

1.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

2.  Oral administration of an immunodominant T-cell epitope downregulates Th1/Th2 cytokines and prevents experimental myasthenia gravis.

Authors:  F Baggi; F Andreetta; E Caspani; M Milani; R Longhi; R Mantegazza; F Cornelio; C Antozzi
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

3.  Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit.

Authors:  D Barchan; M C Souroujon; S H Im; C Antozzi; S Fuchs
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

4.  Potent immunostimulatory dendritic cells can be cultured in bulk from progenitors in normal infant and adult myasthenic human thymus.

Authors:  M E Hill; D J Ferguson; J M Austyn; J Newsom-Davis; H N Willcox
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

5.  Disease-associated prion protein elicits immunoglobulin M responses in vivo.

Authors:  Mourad Tayebi; Perry Enever; Zahid Sattar; John Collinge; Simon Hawke
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.